The effect of citalopram treatment on platelet serotonin function in panic disorders

International Clinical Psychopharmacology

Volumn 15, Issue 2, 2000, Pages 83-91

  Neuger, Jolanta ^a,c   Wistedt, B ^b   Sinner, B ^b   Aberg Wistedt A ^a   Stain Malmgren, R ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

5 HT2 receptor; Panic disorder; Paroxetine binding; Platelets; Serotonin uptake

Indexed keywords

CITALOPRAM; LYSERGIDE; PAROXETINE; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANXIETY; ARTICLE; BINDING AFFINITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BINDING; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; NERVE CELL PLASTICITY; PANIC; PRIORITY JOURNAL; RATING SCALE; RECEPTOR DENSITY; REMISSION; SEROTONIN UPTAKE; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

EID: 0034053199     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200015020-00004     Document Type: Article

References (53)

1. American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn). Washington, DC: American Psychiatric Association.
2. Arora RC, Fichter CG, O'Connor F, Crayton JW (1993) Paroxetìne binding in the blood platelets of post-traumatic stress disorder patients. Life Sci 53:919-928.
3. Asberg M, Traskman L, Thoren P, Bertilsson L, Ringberger VA (1976) Serotonin depression - a biochemical subgroup within the affective disorders? Science 191:478-480.
4. Beck AT, Rush AJ, Shaw BF, Emery G (1979) Cognitive Therapy of Depression: A Treatment Manual. New York: The Guilford Press.
5. Beck AT, Brown G, Epstein N, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56:893-897.
6. Briley M, Chopin P, Moret C (1990) Effect of serotonergic lesion on 'anxious' behaviour measured in the elevated plusmaze test in the rat. Psychopharmacology 101:187-189.
7. Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. Psychopharmacology 92:14-24.
8. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, et al. (1989) Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry 46:587-599.
9. Coccaro EF, Kavoussi RJ, Trestman R, Gabriel SM, Cooper TB, Siever LJ (1997) Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res 73:1-14.
10. Deakin WJF, Graeff FG (1991) Critique. 5-HT and mechanisms of defence. J Psychopharmacol 5:305-315.
11. Den Boer JA, Westenberg HGM (1990) Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology 102:85-94.
12. Den Boer JA, Westenberg HGM, DE Leeuw AS, van Vliet IM (1995) Biological dissection of anxiety disorders: the clinical role of selective scrotonin reuptake inhibitors with particular reference to fluvoxamine. Int Clin Psychopharmacol 9 (Suppl. 4):47-52.
13. 3H-paroxetine binding in depressed patients. Psychiatry Res 26:11-17.
14. 3H-imipramine binding in panic disorder patients and healthy controls. J Psychiatry Neurosci 19:109-113.
15. Fichter CG, O'Connor FL, Yeoh HC, Arora RC, Crayton JW (1995) Hypodensity of platelet serotonin uptake sites in post-traumatic stress disorder: associated clinical features. Life Sci 57:37-44.
16. 2 sites in cortex and amygdala. Brain Res 614:37-44.
17. Humble M, Wistedt B (1992) Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. Int Clin Psychopharmacol 6 (Suppl. 5):21-39.
18. Hyttel J (1977) Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171. Psychopharmacol 51:225-33.
19. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 (Suppl. 1):19-26.
20. 3H-paroxetine binding on human platelets. Biol Psychiatry 36:281-291.
21. Kaplan DR, Mann JJ (1982) Alterad platelet serotonin uptake kinetics in schizophrenia and depression. Life Sci 31:583-588.
22. Keedwell P, Snaith RP (1996) What do anxiety scales measures? Acta Psychiatry Scand 93:177-180.
23. 3H-paroxetine. Psychopharmacology 110:235-239.
24. Lingjærde O (1990) Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants. Pharmacol Toxicol 66 (Suppl. 3):61-68.
25. Lydiard RB, Brawman-Mintzer O, Ballenger JC (1996) Recent developments in the psychopharmacology of anxiety disorders. J Consult Clin Psychol 64:660-668.
26. 2-receptor indices to major depression disorder, personality traits and suicidal behavior. Biol Psychiatry 35:295-308.
27. Malmgren R (1984) Platelets and biogenic amines. Psychopharmacology 84:480-485.
28. Malmgren R, Åberg-Wistedt A, Mårtensson B (1989) Aberrant seasonal variations of platelet serotonin uptake in endogenous depression. Biol Psychiatry 25:393-402.
29. Meltzer HY, Lowy MT (1987) The Serotonin Hypothesis of Depression. Psychopharmacology. Third Generation of Progress. New York: Raven Press, pp. 513-526.
30. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
31. Nemeroff CB (1992) The presynaptic uptake site in depression. Clin Neuropharmacol 15:347A-348A.
32. Neuger J, El Khoury A, Kjellman BF, Wahlund B, Åberg-Wistedt A, Stain-Malmgren R (1999) Platelet serotonin function in untreated major depression. Psychiatry Res 85:189-198.
33. Norman TR, Judd FK, Gregory M, James RH, Kimber NM. McIntyre IM, Burrows GD (1986) Platelet serotonin uptake in panic disorder. J Affect Disord 11:69-72.
34. 3H-imipramine binding in panic disorder. J Affect Disord 17:77-81.
35. Norman TR, Judd FK, Burrows GD, McIntyre IM (1989b) Platelet serotonin uptake in panic disorder patients: a replication study. Psychiatry Res 30:63-68.
36. Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM (1990) Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 28:215-222.
37. 2A receptors: a potential biological marker for suicidal behaviour. Am J Psychiatry 153:850-855.
38. Pecknold JC, Suranyi-Cadotte B, Chang H, Nair NVP (1988) Serotonin uptake in panic disorder and agoraphobia. Neuropsychopharmacol 1:173-176.
39. Petty F, Davis LL, Kabel D, Kramer GL (1996) Serotonin dysfunction disorders: a behavioral neurochemistry perspective. J Clin Psychiatry 57 (Suppl. 8):11-16.
40. Sheehan DV, Raj BA, Trehan RR, Knapp EL (1993) Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 8 (Suppl. 2):63-77.
41. Sheline YI, Bardgett ME, Jackson JL, Newcomer JW, Csernansky JG (1995) Platelet serotonin markers and depressive symptomatology. Biol Psychiatry 37:442-447.
42. Smith PK, Krohn RI, Hermansson GT, Mallia AL, Gartner FH, Provensano MD, et al. (1985) Measurement of protein using bicinchoninic acid. Annal Biochem 150:76-85.
43. Snaith RP, Baugh SJ, Clayden AD, Husain A, Sipple MA (1982) The clinical anxiety scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 141:518-523.
44. Stahl SM (1998) Psychopharmacology of Antidepressants in the United Kingdom. London: Martin Dunitz Ltd.
45. Stein L, Wise CD, Berger BD (1973) Anti-anxiety action of bensodiazepines: decrease in activity of serotonin neurons in the punishment system. In: The Bensodiazepines (Garattini S, Mussine E, Randall LO, eds), New York: Raven Press, pp. 299-326.
46. Taylor S, Koch WJ (1996) Anxiety sensitivity and depression: how are they related? J Abnorm Psychol 105:474-479.
47. Tuomisto J, Tukiainen E (1976) Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262:596.
48. Tuomisto J, Tukiainen E, Ahlfors UG (1979) Decreased uptake of 5-hydroxytryptamine in blood platelets from patients with endogenous depression. Psychopharmacology 65:141.
49. Tye NC, Iversen SA, Green SA (1979) The effects of bensodiazepine and serotonergic manipulations on punished responding. Neuropharmacology 18:689-695.
50. Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T (1997) The effect of citalopram in panic disorder. Br J Psychiatry 170:549-553.
51. Weinstein RS (1995) Panic disorder. Am Family Physician 52:2055-2063.
52. Zacharko RM, Koszycki D, Mendella PD, Bradwejn J (1995) Behavioral, neurochemical, anatomical and electrophysiological correlates of panic disorder: multiple transmitter interaction and neuropeptide colocalization. Progr Neurobiol 47:371-423.
53. Zivin JA, Waud RD (1982) Minireview. How to analyse binding, enzyme and uptake data: the simplest case, a single phase. Life Sci 30:1407-1422.